Tydemy oral birth control recalled, FDA warns that reduced efficacy may result in unexpected pregnancies

Aug 14, 2023

PH Drip Lab owner Dr. Pauline Jose and Prime IV franchise owner Dr. Christopher Neary explain why IV drip therapy has gained popularity and what vitamins they’re serving to clients.

Lupin Pharmaceuticals has recalled two batches of the oral birth control Tydemy due to reduced effectiveness that may result in unexpected pregnancies for users.

The FDA said that the pills were voluntarily recalled after manufacturers realized that the oral contraception contained a decreased level of ascorbic acid, an ingredient in the product, and high levels of a "known impurity."

The company said the low levels of ascorbic acid "could potentially impact the effectiveness of the product which could potentially result in unexpected pregnancy." However, the FDA noted that they have not received any reports of "adverse events related to using this product."

Lupin Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of 2 Lots of Tydemy (FDA)

The Federal Food and Drug Administration warned that the recalled batches of the Tydemy could result in pregnancies. (iStock)

The recalled batches of the Tydemy pills, a combination prescription contraceptive of estrogen and progestin, are lots L200183 and L201560 and were distributed by pharmacies across the U.S. from June 3, 2022, to May 31, 2023. Consumers can find the lot number on the side of the label.

AI BABIES: NEW TECHNOLOGY IS HELPING FERTILITY DOCS CHOOSE THE BEST EMBRYOS FOR IVF

According to the FDA, a total of 4,179 boxes of the oral birth control have been recalled.

People who are currently taking recalled lots of the drugs are urged to continue taking their pills but immediately seek out an alternative from their doctor.

A woman takes the next pill from the monthly pack of the contraceptive pill. (Annette Riedl/picture alliance via Getty Images)

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

This is not Lupin Pharmaceuticals' first voluntary recall.

In December of last year, Lupin recalled one batch of 20-milligram Quinapril Tablets USP and three batches of 40-milligram Quinapril Tablets USP due to the potential presence of a nitrosamine impurity.

CLICK HERE TO GET THE FOX NEWS APP

Sarah Rumpf-Whitten is a writer on the breaking news team for Fox News Digital. You can reach her on Twitter at @s_rumpfwhitten.

Stay up-to-date on the biggest health and wellness news with our weekly recap.

Subscribed

You've successfully subscribed to this newsletter!